Tumors of the Central Nervous System Gliomas Glioblastoma (Part 1.

By:

M.A. Hayat

Material type: Text

TextLanguage: English Series: Tumors of the Central Nervous System ; Volume 1Publication details: London | Springer Science+Business Media B.V | 2011Description: 456 Pages; Includes References and IndexISBN:

978-94-007-0343-8
978-94-007-0344-5

Subject(s):

-- Gliomas, Biochemical markers, Biomedicine, Central nervous system -- Tumors, Gliomas -- Diagnosis -- Treatment, Medical radiology, Medicine, Nervous system -- Surgery, Oncology, Pathology, Surgery

DDC classification:

616.994 HAY

Online resources:

Click here to access online

Summary: The most recent developments in diagnostic and therapeutic aspects of Gliomas (Glioblastoma) in the brain are presented. The importance of personalized medicine and clinical validation for targeted therapy are discussed. The identification of various types of biomarkers is included. The identification and validation of brain cancer (glioblastoma) genes are discussed. Role of cancer stem cells in the initiation, progression, and persistence of malignant gliomas is explained. The use of surgical resection, chemotherapy (e.g., temozolomide), immunotherapy, and radiotherapy for malignant glioblastoma are pointed out. Standard (established) as well as newer imaging modalities (proton magnetic resonance spectroscopy) are discussed.

Item type: E-BOOKS

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Call number	URL	Status	Barcode
E-BOOKS	MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO	616.994 HAY (Browse shelf(Opens below))	Link to resource	Not for loan	20241021085741.0

Total holds: 0

The most recent developments in diagnostic and therapeutic aspects of Gliomas (Glioblastoma) in the brain are presented. The importance of personalized medicine and clinical validation for targeted therapy are discussed. The identification of various types of biomarkers is included. The identification and validation of brain cancer (glioblastoma) genes are discussed. Role of cancer stem cells in the initiation, progression, and persistence of malignant gliomas is explained. The use of surgical resection, chemotherapy (e.g., temozolomide), immunotherapy, and radiotherapy for malignant glioblastoma are pointed out. Standard (established) as well as newer imaging modalities (proton magnetic resonance spectroscopy) are discussed.

There are no comments on this title.

to post a comment.